Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 16051-16100 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03408665
Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer
NAActive, not recruiting
280 participants
Started: Mar 13, 2019 · Completed: Dec 1, 2027
2 conditions2 sponsors7 locations
NCT03900949
Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia
PHASE1Active, not recruiting
18 participants
Started: Mar 13, 2019 · Completed: Dec 1, 2025
1 condition1 sponsor2 locations
NCT03591510
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
PHASE2Active, not recruiting
22 participants
Started: Mar 13, 2019 · Completed: Oct 31, 2030
1 condition1 sponsor17 locations
NCT04218812
Clinical Utility of Automated Electric Source Imaging in Presurgical Evaluation
NAActive, not recruiting
250 participants
Started: Mar 12, 2019 · Completed: Dec 31, 2024
4 conditions13 sponsors12 locations
NCT03708731
Exploring Adherence Monitoring in Sickle Cell Disease
N/AActive, not recruiting
36 participants
Started: Mar 12, 2019 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT03713580
Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma
PHASE1Active, not recruiting
25 participants
Started: Mar 12, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT03843359
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
PHASE1Active, not recruiting
97 participants
Started: Mar 12, 2019 · Completed: Mar 31, 2025
1 condition1 sponsor13 locations
NCT03809780
Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone
PHASE2Active, not recruiting
70 participants
Started: Mar 11, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03708003
Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL
PHASE2Active, not recruiting
30 participants
Started: Mar 11, 2019 · Completed: Dec 31, 2026
3 conditions1 sponsor11 locations
NCT03701399
Troriluzole in Adult Participants With Spinocerebellar Ataxia
PHASE3Active, not recruiting
299 participants
Started: Mar 8, 2019 · Completed: Oct 31, 2025
8 conditions1 sponsor23 locations
NCT03892265
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
N/AActive, not recruiting
3,005 participants
Started: Mar 8, 2019 · Completed: Aug 1, 2028
14 conditions3 sponsors1 location
NCT03789110
NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
PHASE2Active, not recruiting
30 participants
Started: Mar 8, 2019 · Completed: Dec 30, 2025
1 condition2 sponsors3 locations
NCT03935763
Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective
N/AActive, not recruiting
738 participants
Started: Mar 8, 2019 · Completed: Nov 30, 2024
1 condition1 sponsor18 locations
NCT03972514
Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors.
N/AActive, not recruiting
60 participants
Started: Mar 8, 2019 · Completed: Mar 31, 2030
3 conditions2 sponsors1 location
NCT03671148
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
PHASE3Active, not recruiting
444 participants
Started: Mar 7, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor138 locations
NCT03837899
Durvalumab and Tremelimumab for Pediatric Malignancies
PHASE1/PHASE2Active, not recruiting
50 participants
Started: Mar 7, 2019 · Completed: Dec 30, 2024
3 conditions1 sponsor19 locations
NCT03355105
Comparison of Two Methods of Adjusting the Mechanical In-Exsuflation in Neuromuscular Adult Patients
NAActive, not recruiting
29 participants
Started: Mar 7, 2019 · Completed: Dec 24, 2024
1 condition1 sponsor1 location
NCT03833154
Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation
PHASE3Active, not recruiting
724 participants
Started: Mar 6, 2019 · Completed: Apr 4, 2028
1 condition1 sponsor209 locations
NCT03617679
Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer
PHASE2Active, not recruiting
79 participants
Started: Mar 6, 2019 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT03732950
Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer
PHASE2Active, not recruiting
5 participants
Started: Mar 6, 2019 · Completed: Mar 6, 2025
3 conditions2 sponsors3 locations
NCT03610711
REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer
PHASE1/PHASE2Active, not recruiting
21 participants
Started: Mar 6, 2019 · Completed: Dec 31, 2025
2 conditions2 sponsors3 locations
NCT03696225
Assessment and Treatment of Cognitive Functioning Deficits in Veterans With PTSD
NAActive, not recruiting
21 participants
Started: Mar 6, 2019 · Completed: Dec 29, 2025
1 condition1 sponsor1 location
NCT03833700
A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)
PHASE1Active, not recruiting
70 participants
Started: Mar 5, 2019 · Completed: Jan 31, 2026
3 conditions1 sponsor8 locations
NCT03795337
Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-II)
NAActive, not recruiting
475 participants
Started: Mar 5, 2019 · Completed: Dec 31, 2025
1 condition3 sponsors8 locations
NCT03889132
Glucose, Brain and Microbiota
N/AActive, not recruiting
128 participants
Started: Mar 5, 2019 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT03935256
Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer
PHASE2Active, not recruiting
24 participants
Started: Mar 5, 2019 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06566391
Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma
PHASE2Active, not recruiting
35 participants
Started: Mar 5, 2019 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT03757949
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery
PHASE3Active, not recruiting
203 participants
Started: Mar 5, 2019 · Completed: Jan 1, 2027
1 condition2 sponsors46 locations
NCT03865992
Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease
NAActive, not recruiting
42 participants
Started: Mar 4, 2019 · Completed: Oct 17, 2025
2 conditions2 sponsors4 locations
NCT03842033
Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients
NAActive, not recruiting
370 participants
Started: Mar 4, 2019 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT03851133
Florida Pancreas Collaborative Next Generation Biobank
N/AActive, not recruiting
500 participants
Started: Mar 4, 2019 · Completed: Jun 11, 2026
2 conditions1 sponsor14 locations
NCT03786783
Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
PHASE2Active, not recruiting
42 participants
Started: Mar 4, 2019 · Completed: Sep 19, 2026
2 conditions1 sponsor10 locations
NCT03943680
Plasma Rich in Growth Factors in Post-extraction Sockets
NAActive, not recruiting
30 participants
Started: Mar 4, 2019 · Completed: Jul 31, 2025
2 conditions2 sponsors1 location
NCT02950766
NeoVax Plus Ipilimumab in Renal Cell Carcinoma
PHASE1Active, not recruiting
19 participants
Started: Mar 3, 2019 · Completed: May 30, 2030
1 condition3 sponsors1 location
NCT04245644
Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study
N/AActive, not recruiting
800 participants
Started: Mar 2, 2019 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT03612271
mGlide RCT: A Clinical Glide Path To Close the Guideline-to-Practice Gap In HTN Management
NAActive, not recruiting
395 participants
Started: Mar 1, 2019 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT03269708
Improving Cardiac Secondary Prevention
NAActive, not recruiting
200 participants
Started: Mar 1, 2019 · Completed: Sep 30, 2024
2 conditions1 sponsor1 location
NCT03833089
Targeted Potassium Levels for Prevention of ICD Therapy
PHASE4Active, not recruiting
1,200 participants
Started: Mar 1, 2019 · Completed: Apr 1, 2035
6 conditions2 sponsors3 locations
NCT03706664
Small Bowel Deep Learning Algorithm Project
NAActive, not recruiting
226 participants
Started: Mar 1, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04124198
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma
NAActive, not recruiting
138 participants
Started: Mar 1, 2019 · Completed: Jan 31, 2029
19 conditions5 sponsors3 locations
NCT04009148
Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome
N/AActive, not recruiting
118 participants
Started: Mar 1, 2019 · Completed: Apr 23, 2027
8 conditions1 sponsor1 location
NCT03839771
A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy
PHASE3Active, not recruiting
968 participants
Started: Mar 1, 2019 · Completed: Sep 19, 2034
2 conditions2 sponsors181 locations
NCT03729544
Computerized Decision Support to Increase Detection of Chronic Thromboembolic Pulmonary Hypertension in Patients With Prior Pulmonary Embolism
NAActive, not recruiting
400 participants
Started: Mar 1, 2019 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT04138914
Phase II Trial of Focal Cryotherapy for Prostate Cancer
NAActive, not recruiting
30 participants
Started: Mar 1, 2019 · Completed: Mar 31, 2041
1 condition1 sponsor1 location
NCT03752892
Partitioned Training of Patients with Idiopathic Pulmonary Fibrosis
NAActive, not recruiting
50 participants
Started: Mar 1, 2019 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT04488198
Acupuncture in Pediatrics and Adolescents With Chronic Inflammatory Bowel Diseases
NAActive, not recruiting
60 participants
Started: Mar 1, 2019 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT03602105
Better Before - Better After: Prehabilitation Program for Older Patients Awaiting Total Hip Replacement
NAActive, not recruiting
103 participants
Started: Mar 1, 2019 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT03771651
Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube
EARLY_PHASE1Active, not recruiting
18 participants
Started: Mar 1, 2019 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT03890237
GAGE Act With Her-Ethiopia Evaluation
NAActive, not recruiting
4,500 participants
Started: Mar 1, 2019 · Completed: Nov 30, 2026
2 conditions8 sponsors3 locations
NCT03808467
Cognitive Training for Patients With Eating Disorders
NAActive, not recruiting
100 participants
Started: Mar 1, 2019 · Completed: Jul 31, 2026
4 conditions3 sponsors3 locations